Chardan Upgrades Regeneron; Cites Fovista Failure, Stock's Recent Underperformance
December 12, 2016 at 08:28 AM EST
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has underperformed Amgen, Inc. (NASDAQ: AMGN) as well as the NBI year-to-date in 2016, ...